Speakers
Karl-Heinz Huemer, MD, PhD
Clinical Assessor, Scientific Office, Austrian Medicines and Medical Devices Agency (AGES), Austria
PhD (in biology) and MD University of Vienna research at Medical University of Vienna (main area neuroscience) since 2007 assessor at the Austrian Medicines Agency full member in EMA - Paediatric Committee (PDCO) alternate member in EMA - CHMP Scientific Advice Working Party (SAWP)
Klaus Rose, MD, MS
Chief Executive Officer, klausrose Consulting, Switzerland
Klaus Rose, a German MD with postgraduate degrees in General & Pharmaceutical Medicine, was 20 years with Big Pharma. In 2001, he became Global Head Pediatrics at Novartis & 2005 at Roche ; CEO of klausrose Consulting since 2011. He advises on pediatric drug development and FDA/EMA pediatric requirements. Private interests: languages, classical guitar, cooking, wine & gardening
Christina Bucci-Rechtweg, MD
Global Head, Maternal Health and Pediatric Regulatory Policy, Novartis , United States
Christina is Global Head of Pediatric & Maternal Health Policy at Novartis. She graduated from the U Rochester Sch of Medicine & Dentistry and trained in Peds/Pediatric Critical Care Medicine at SUNY Buffalo. She has 20+ yrs of experience in Clinical Development and Regulatory Policy. Her activities advancing the environment for pediatric and maternal health include: ICH E11A Expert Work Group, C-Path International Neonatal Consortium, EFGCP Children's Medicines WP, IQ Consortia Clin Pharm Leadership Group Pediatric WG & NIH/NICHD National Advisory Council on Child Health & Human Development. In her career, Christina has over 40 peer-review published articles and 100 invited lectures.
Have an account?